z-logo
open-access-imgOpen Access
Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer
Author(s) -
Karen Page,
David S. Guttery,
Daniel Fernández-García,
Allison Hills,
Robert Hastings,
Jinli Luo,
Kate Goddard,
Vedia Shahin,
Laura Woodley-Barker,
Brenda Rosales,
R. Charles Coombes,
Justin Stebbing,
Jacqui Shaw
Publication year - 2016
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2016.261834
Subject(s) - amplicon , breast cancer , metastatic breast cancer , cold pcr , digital polymerase chain reaction , biology , cancer research , somatic evolution in cancer , gene duplication , cancer , somatic cell , cell free fetal dna , mutation , copy number variation , estrogen receptor , germline mutation , gene , point mutation , polymerase chain reaction , genetics , genome , pregnancy , fetus , prenatal diagnosis
Breast cancer tissues are heterogeneous and show diverse somatic mutations and somatic copy number alterations (CNAs). We used a novel targeted next generation sequencing (NGS) panel to examine cell-free DNA (cfDNA) to detect somatic mutations and gene amplification in women with metastatic breast cancer (MBC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom